康龍(long)(long)(long)化(hua)成(cheng)(cheng)新(xin)藥(yao)(yao)(yao)(yao)技術(shu)股份有限公(gong)司(si),成(cheng)(cheng)立于2004年(nian),是國(guo)際生命(ming)科學(xue)研發(fa)服務(wu)企業(ye)。公(gong)司(si)使命(ming)為(wei)“以高(gao)水平(ping)的(de)(de)(de)研發(fa)服務(wu),幫助合(he)作(zuo)伙伴(ban)們成(cheng)(cheng)功開發(fa)新(xin)藥(yao)(yao)(yao)(yao),為(wei)人類健(jian)康貢獻康龍(long)(long)(long)化(hua)成(cheng)(cheng)智(zhi)慧(hui)。”經過十多年(nian)的(de)(de)(de)發(fa)展(zhan),康龍(long)(long)(long)化(hua)成(cheng)(cheng)打造了藥(yao)(yao)(yao)(yao)物(wu)(wu)研發(fa)一體化(hua)平(ping)臺,貫穿(chuan)合(he)成(cheng)(cheng)與(yu)藥(yao)(yao)(yao)(yao)物(wu)(wu)化(hua)學(xue)、生物(wu)(wu)、藥(yao)(yao)(yao)(yao)物(wu)(wu)代(dai)謝(xie)(xie)及藥(yao)(yao)(yao)(yao)代(dai)動力學(xue)、藥(yao)(yao)(yao)(yao)理(li)、藥(yao)(yao)(yao)(yao)物(wu)(wu)安全評(ping)價(jia)、放(fang)射標記(ji)代(dai)謝(xie)(xie)、工(gong)藝研發(fa)、GMP生產及制劑研發(fa)服務(wu)等各個(ge)領域(yu),提供(gong)包(bao)括(kuo)苗頭化(hua)合(he)物(wu)(wu)探索與(yu)靶(ba)標驗證、先(xian)導化(hua)合(he)物(wu)(wu)優化(hua)、臨床前(qian)候選(xuan)藥(yao)(yao)(yao)(yao)物(wu)(wu)篩(shai)選(xuan)、新(xin)藥(yao)(yao)(yao)(yao)臨床開發(fa)和(he)新(xin)藥(yao)(yao)(yao)(yao)上市申報等一體化(hua)服務(wu)。康龍(long)(long)(long)化(hua)成(cheng)(cheng)在(zai)中國(guo)、美國(guo)、英國(guo)均有運營實體,擁有7000多名員工(gong),人才隊伍,高(gao)質量的(de)(de)(de)研發(fa)服務(wu),獲(huo)得(de)了業(ye)界的(de)(de)(de)廣(guang)泛認可,與(yu)北美、歐洲、日本(ben)和(he)中國(guo)的(de)(de)(de)各醫藥(yao)(yao)(yao)(yao)公(gong)司(si)/機(ji)構保持著穩固(gu)的(de)(de)(de)合(he)作(zuo)關系。